Literature DB >> 29175586

Design, synthesis of novel Triazolones and bis-Triazolones derivatives under ultrasound irradiation and evaluation as potent angiotensin converting enzyme (ACE) inhibitors.

Bochra Ben Salah1, Salwa Hamzaoui2, Fatma Krichen3, Ikram Saadaoui2, Riadh Ben Mansour4, Nabil Miled5, Ali Bougatef3, Mohamed Kossentini2.   

Abstract

The condensation of several primary amines and diamines with various N1-ethoxycarbonyles N1-tosylhydrazonates (1a-b), triazolones (2) and bis-triazolone (3) resulted in ethanol under ultrasound irradiation. Compared with the conventional methods, the main advantages of the present procedure are milder conditions, shorter reaction time and higher yields. The newly synthesized compounds were evaluated for angiotensin I-converting enzyme (ACE) inhibition. The results were compared to Captopril as a reference drug. Compounds 3b, 2h, 3a, 2d, and 2f showed not only inhibition activity with IC50 values of 0.162, 0.253, 0.253, 0.281 and 0.382 µM, respectively, but also minimal toxicity. The docking of chemical compounds in the ACE active site showed possible inhibitory effect of all compounds on the catalytic activity of the enzyme, which would satisfactorily explain the anti-hypertensive effect of these compounds.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiotensin I-converting enzyme (ACE) inhibitory activity; N(1)-ethoxycarbonyles N(1)-tosylhydrazonates; Triazolones; Ultrasound; bis-Triazolones

Mesh:

Substances:

Year:  2017        PMID: 29175586     DOI: 10.1016/j.bioorg.2017.11.004

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

1.  Enzymatic Protein Hydrolysates, and Ultrafiltered Peptide Fractions from Two Molluscs: Tympanotonus fuscatus var. radula (L.) and Pachymelania aurita (M.), with Angiotensin-I-Converting Enzyme Inhibitory and DPPH Radical Scavenging Activities.

Authors:  Abraham Abbey Paul; Queensley Adesuwa Eghianruwa; Olayemi Grace Oparinde; Adetunji Samuel Adesina; Omolaja Osoniyi
Journal:  Int J Appl Basic Med Res       Date:  2021-04-08

Review 2.  Considerations for Docking of Selective Angiotensin-Converting Enzyme Inhibitors.

Authors:  Julio Caballero
Journal:  Molecules       Date:  2020-01-11       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.